Showing results (1471-1480 of 6,507) with videos related to
Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|September 5, 2024
A comprehensive and longitudinal evaluation of the different populations of lymphoid and myeloid cells in the peripheral blood of patients treated with chemoradiotherapy for head and neck cancerJens von der Grün, Martina Broglie, Matthias Guckenberger, et al.Cancer Immunology, Immunotherapy : CII|September 9, 2024
Adjuvant chemoradiotherapy plus pembrolizumab for locally advanced esophageal squamous cell carcinoma with high risk of recurrence following neoadjuvant chemoradiotherapy: a single-arm phase II studyJhe-Cyuan Guo, Ta-Chen Huang, Hung-Yang Kuo, et al.Cancer Immunology, Immunotherapy : CII|September 5, 2024
The short-term efficacy of neoadjuvant SOX versus SOX plus immune checkpoint inhibitor following laparoscopic gastrectomy for locally advanced gastric cancer: a multicenter retrospective cohort study in ChinaHao Cui, Yongpu Yang, Liqiang Song, et al.Cancer Immunology, Immunotherapy : CII|September 5, 2024
High proportion of PD-1 and CD39 positive CD8+ tissue resident T lymphocytes correlates with better clinical outcome in resected human oesophageal adenocarcinomaSamuel L Hill, Gessa Sugiyarto, Jack Harrington, et al.Cancer Immunology, Immunotherapy : CII|September 5, 2024
Oncolytic virotherapy augments self-maintaining natural killer cell line cytotoxicity against neuroblastomaColin H Quinn, Janet R Julson, Hooper R Markert, et al.Cancer Immunology, Immunotherapy : CII|November 7, 2024
Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancerCecilia Olsson Ladjevardi, Marcus Skribek, Anthoula Koliadi, et al.Cancer Immunology, Immunotherapy : CII|November 11, 2024
Pretransplant immunotherapy increases acute rejection yet improves survival outcome of HCC patients with MVI post-liver transplantationXinjun Lu, Qi Zhu, Junfeng Cai, et al.Cancer Immunology, Immunotherapy : CII|August 6, 2024
CD27 signaling inhibits tumor growth and metastasis via CD8 + T cell-independent mechanisms in the B16-F10 melanoma modelEswara Rao Puppala, Long Wu, Xiaoxuan Fan, et al.Cancer Immunology, Immunotherapy : CII|August 7, 2024
NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunityAurelie Herault, Judy Mak, Josefa de la Cruz-Chuh, et al.Cancer Immunology, Immunotherapy : CII|August 7, 2024
DNA hypo-methylation and expression of GBP4 induces T cell exhaustion in pancreatic cancerYesiboli Tasiheng, Xuan Lin, Xu Wang, et al.Pageof 651